Buy
Sell
Share Name Share Symbol Market Type Share ISIN Share Description
Biotech Growth Trust (the) Plc LSE:BIOG London Ordinary Share GB0000385517 ORD 25P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  28.00 1.93% 1,482.00 1,474.00 1,482.00 1,484.00 1,458.00 1,480.00 136,406 16:35:15
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Equity Investment Instruments 1.3 0.7 1.0 1,482.0 598

Biotech Growth Share Discussion Threads

Showing 301 to 323 of 325 messages
Chat Pages: 13  12  11  10  9  8  7  6  5  4  3  2  Older
DateSubjectAuthorDiscuss
15/9/2020
14:39
Immunomedics - amazing deal!
raldo
14/9/2020
16:32
Maybe the Gilead move
shaker44
14/9/2020
16:07
Wow, what's moved in the p/f for that move to occur?
scottishfield
14/9/2020
14:06
Serious move up here! Wonder what's up.
raldo
25/7/2020
20:12
My guess is further gains, its a new covid world but may go sideways and consolidate for a while.
its the oxman
25/7/2020
14:52
oxman- now at a premium- does this present a risk or do you think it sill has got legs?
ali47fish
08/7/2020
10:07
1370p and now trading at a premium to nav - reflecting the new covid world .
its the oxman
07/7/2020
19:47
Taken a few profits here but it's still going up.
its the oxman
12/5/2020
17:16
Hoping to see discount eliminated soon if performance continues. Cant see biotech healthcare giving up much while covid continues.
its the oxman
12/5/2020
16:06
I'm up 25% with this stock
dekle
06/5/2020
13:02
Chart says 1300p to me.
its the oxman
29/4/2020
07:39
Definitely the sector to be in - this or tech, and difference is profitability!
adae
27/4/2020
11:40
Bought in this morning. Can see this being a hot sector for some time to come.
starpukka
16/1/2020
09:56
Discount seems far too large, my thinking is at somepoint investor desire for the fangs will weaken and biotechs with new new breakthroughs underpinned by ever increasing demand from ageing populations etc could easily take over. Not a bad area to have some exposure to regardless.
its the oxman
01/8/2019
15:04
That's because IBT has a dividend yield of 4% and has outperformed its index. Seems like YTD BIOG is performing better, but need to sustain this to improve its long term performance.
healthtech
29/7/2019
15:56
IBT on slight premium to NAV whereas BIOG at a discount . Very similar funds, I would expect BIOG to catch up at some point
rogerrail
04/7/2019
08:06
Oxman , appears you were right.
the oak tree
01/11/2018
13:52
Good time to buy sub 700p ?
its the oxman
04/4/2018
09:33
Or maybe the funds management are too busy sipping champagne on our money to notice the money we trusted them with is evaporating.
andyj
03/4/2018
23:56
Share price nearly 10% below NAV now, should see some buy backs.
andyj
28/3/2018
16:06
I will settle for getting my money back
andyj
28/3/2018
07:06
Will be £10+ before years out..
losses
26/3/2018
13:45
9% drop in the NAV last week.
andyj
Chat Pages: 13  12  11  10  9  8  7  6  5  4  3  2  Older
ADVFN Advertorial
Your Recent History
LSE
BIOG
Biotech Gr..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20201128 02:06:48